Skip to main content
FDA Approvals, In the News, Select Drug Profiles
FDA Grants Approval to Avapritinib for Patients with GIST
Read More
FDA Approvals, In the News, Select Drug Profiles
Recap of FDA Drug Approvals in 2019
Read More
FDA Approvals, In the News, Select Drug Profiles
Regenerative Medicine Advanced Therapy Designation Granted to ADP-A2M4 for Synovial Sarcoma
Read More
Drug Updates, FDA Approvals, In the News, Select Drug Profiles
November 11, 2019 — Oncology News & Updates
Read More
FDA Approvals, In the News, Select Drug Profiles
October 28, 2019 – Oncology News & Updates
Read More
Breast Cancer, FDA Approvals, In the News, Multiple Myeloma, Pediatric Cancer, Select Drug Profiles
Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News
Read More
FDA Approvals, Multiple Myeloma, In the News, Select Drug Profiles
FDA Approves Darzalex Combination for First-Line Treatment of Transplant-Eligible Patients with Multiple Myeloma
Read More
Select Drug Profiles
Eylea (Aflibercept), a VEGF Receptor Inhibitor, Receives New Indication for All Stages of Diabetic Retinopathy
Lilly Ostrovsky
Lilly Ostrovsky
Read More
Select Drug Profiles
Imbruvica (Ibrutinib) plus Gazyva (Obinutuzumab) First Chemotherapy-Free Combination Approved as First-Line Treatment for Patients with CLL or SLL
Lilly Ostrovsky
Lilly Ostrovsky
Read More
Select Drug Profiles
Mavenclad (Cladribine) First Short-Course Oral Therapy Approved for Relapsing-Remitting Multiple Sclerosis and Active Secondary Progressive Disease
Lilly Ostrovsky
Lilly Ostrovsky
Read More
Page 5 of 20
Results 41 - 50 of 200